OKYO Pharma (OKYO) Receivables - Other (2021 - 2026)
OKYO Pharma (OKYO) posted quarterly Receivables - Other of $144320.0 for Q1 2026, up 3107.11% year-over-year from $4500.0 in Q1 2025, and down 65.82% quarter-over-quarter from $422281.0 in Q3 2025.
OKYO Pharma (OKYO) Receivables - Other (2021 - 2026) Analysis & Trends
OKYO Pharma (OKYO) has reported Receivables - Other for 6 consecutive years, with $144320.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Receivables - Other rose 3107.11% year-over-year to $144320.0; the TTM figure through Mar 2026 stood at $144320.0 (up 3107.11% YoY), while the FY2026 annual figure was $144320.0, up 259.64% from the prior year.
- Receivables - Other slipped to $144320.0 in Q1 2026 per OKYO's latest filing, from $422281.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $422281.0 in Q3 2025 and bottomed at $4500.0 in Q1 2025.
- Historically, Receivables - Other has averaged $211218.5 across 5 years, with a median of $242584.0 in 2023.
- Annual changes were most pronounced in 2024 — Receivables - Other tumbled 98.36% — and 2026, when it jumped 3107.11%.
- OKYO Pharma's Receivables - Other stood at $19130.0 in 2022, then jumped by 1973.99% to $396755.0 in 2023, then fell by 10.19% to $356329.0 in 2024, then rose by 18.51% to $422281.0 in 2025, then slumped by 65.82% to $144320.0 in 2026.
- Business Quant data shows OKYO's Receivables - Other at $144320.0 in Q1 2026, $422281.0 in Q3 2025, and $4500.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | OKYO Pharma | 1.47 Bn | 1.47 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 144,320.00 |
| Mar 31, 2026 | 144,320.00 |
| Sep 30, 2025 | 422,281.00 |
| Sep 30, 2025 | 422,281.00 |
| Mar 31, 2025 | 4,500.00 |
| Mar 31, 2025 | 4,500.00 |
| Sep 30, 2024 | 356,329.00 |
| Sep 30, 2024 | 356,329.00 |
| Mar 31, 2024 | 5,585.00 |
| Mar 31, 2024 | 5,585.00 |
| Sep 30, 2023 | 396,755.00 |
| Sep 30, 2023 | 396,755.00 |
| Mar 31, 2023 | 340,848.00 |
| Mar 31, 2023 | 340,848.00 |
| Mar 31, 2022 | 19,130.00 |
| Mar 31, 2022 | 19,130.00 |
| Mar 31, 2021 | 43,371.00 |
| Mar 31, 2021 | 43,371.00 |